Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引:20
|
作者
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
关键词
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I
10.1007/s002590000333
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码:1465 / 1472
页数:8
相关论文
共 50 条
  • [21] Radioiodine refractory differentiated thyroid cancer
    Jin, Yuchen
    Van Nostrand, Douglas
    Cheng, Lingxiao
    Liu, Min
    Chen, Libo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 111 - 120
  • [22] Radioiodine refractory differentiated thyroid cancer
    Boudina, Maria
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 65 - 68
  • [23] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Barbaro, Daniele
    Campenni, Alfredo
    Forleo, Raffaella
    Lapi, Paola
    ENDOCRINE, 2023, 81 (01) : 30 - 35
  • [24] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Daniele Barbaro
    Alfredo Campennì
    Raffaella Forleo
    Paola Lapi
    Endocrine, 2023, 81 : 30 - 35
  • [25] Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review
    Gambale, Carla
    Elisei, Rossella
    Matrone, Antonio
    MINERVA ENDOCRINOLOGICA, 2020, 45 (04) : 306 - 317
  • [26] Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment
    Chiapponi, Costanza
    Hartmann, Milan Janis Michael
    Decarolis, Boris
    Simon, Thorsten
    Bruns, Christiane Josephine
    Faust, Michael
    Schultheis, Anne Maria
    Schmidt, Matthias
    Alakus, Hakan
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2023, 15 (03) : 257 - 263
  • [27] Differentiated Thyroid Cancer: How Do Current Practice Guidelines Affect Management?
    Owens, Patrick W.
    McVeigh, Terri P.
    Fahey, Eoin J.
    Bell, Marcia
    Quill, Denis S.
    Kerin, Michael J.
    Lowery, Aoife J.
    EUROPEAN THYROID JOURNAL, 2018, 7 (06) : 319 - 326
  • [28] Differentiated Thyroid Cancer: How Do Current Practice Guidelines Affect Management?
    Owens, P.
    McVeigh, T.
    Bell, M.
    Lowery, A.
    Quill, D.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S342 - S342
  • [29] Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
    Tumino, Dario
    Frasca, Francesco
    Newbold, Kate
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [30] Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
    Fabian Pitoia
    Rafael Selbach Scheffel
    Ines Califano
    Alicia Gauna
    Hernán Tala
    Fernanda Vaisman
    Alejandro Roman Gonzalez
    Ana Oliveira Hoff
    Ana Luiza Maia
    Reviews in Endocrine and Metabolic Disorders, 2024, 25 : 109 - 121